Matter Neuroscience

Matter Neuroscience is a neuroscience and wellness company based in Boulder, Colorado, founded in 2019. The company focuses on understanding the connection between brain chemistry and emotional well-being, aiming to help individuals lead longer, healthier, and happier lives. Matter has successfully raised $26 million in Series A funding as of 2024.

The company is dedicated to identifying a universal biomarker for happiness by studying the neurotransmitters that influence human well-being. Matter collaborates with prominent scientific institutions, including Maastricht University and the Icahn School of Medicine at Mount Sinai. Its primary consumer offering is an iOS app that allows users to track their positive experiences, understand the underlying neurotransmitter activity, and access educational resources on the neuroscience of happiness. The app provides personalized insights to help users improve their health and happiness.